HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Post-Pandemic Stocks

1,328.283

+26.0782.00%

Number of Gainers:13

Number of Losers:3

Number of Flat:2

PE:- -

High:1,338.994

Open:1,302.395

Low:1,302.395

Close:1,302.205

Volume:515.21M

Turnover:4.86B

Market Cap:890.82B

Float Cap:743.33B

Loading ...

JD.com Makes History with Record-Breaking Singles' Day Performance, Securing Industry Leadership

Daxing Airport Economic Zone Global Investment Partner Conference Unveils Major Collaboration Opportunities

CanSino Biologics Begins Phase 1 Trial of Tuberculosis Booster Vaccine in Indonesia

MT Newswires Live

JD Health International's Profit Balloons 97% in Q3

MT Newswires Live

JD Health International Inc. Announces Date for Extraordinary General Meeting

JD HEALTH (06618) Reports Q3 Earnings with Operating Profit of RMB1.243 Billion, Up 125.3% YoY

JD Health International Inc. Shareholders to Vote on Proxy Proposal for Renewal of Continuing Connected Transactions at Upcoming EGM

BRIEF-JD Health International Posts Qtrly Non-IFRS Profit RMB1.90 Billion

JD Health International Reports Strategic Partnerships and New Drug Launches in Q3 2025

JD Health International - Qtrly Revenue RMB17.12 Bln

THOMSON REUTERS

CSPC Pharmaceutical Group Stock Rallies 3.8% in Hong Kong

IPO Preview: Can Haina Pharma's "CXO + Proprietary Pipeline" Model Shine in Hong Kong?

AH Premium Rate and Deviation Rankings as of November 13

HK Stock Movement | GENFLEET-B (02595) Surges Over 8% in Late Trading as GFH375 Tablets Enter Phase III Clinical Trial for Metastatic Pancreatic Cancer

IPO Preview | Weijian Pharma: Doubling H1 2025 Revenue Ahead of Listing

CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products

ClouDr Group - Agreement to Expand Online Sales for Remifemin, Others

THOMSON REUTERS

ClouDr Group Ltd - Enters Service Cooperation Agreement With JD Health

THOMSON REUTERS

ASCLETIS-B (01672) Rises Over 4% Again as ASC36 and ASC35 Combo Advances to Clinical Development

Pharmaceutical Sector Boosted as FDA Leadership Change Restores Market Confidence, Drug Stocks Hit Record Highs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1328.283,"timestamp":1763021314092,"preClose":1302.2053,"halted":0,"volume":515205101,"delay":0,"changeRate":0.020026,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":26.077637,"latestTime":"11-13 16:00:00","open":1302.3949,"high":1338.9937,"low":1302.3949,"amount":4863729637,"amplitude":0.028105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763083800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762997400000,1763006400000],[1763010000000,1763020800000]],"pbRate":2.444255,"peRate":26.385159,"turnoverRate":0.006794,"increases":13,"decrements":3,"flats":1,"marketCap":890823502400,"floatMarketCap":743327962944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1338.9937,"amplitude":0.028105,"preClose":1302.2053,"low":1302.3949,"pbRate":"2.444255","latestPrice":1328.283,"volume":515205101,"delay":0,"open":1302.3949,"prevYearClose":787.97723,"prevWeekClose":1243.435,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1268.661,"twentyDayClose":1383.431,"sixtyDayClose":1440.992,"secType":"PLATE","market":"HK","turnoverRate":0.006794,"peRate":26.385159,"marketCap":890823502400,"floatMarketCap":743327962944,"timestamp":1763021314092,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":13,"down":3,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1143508794","title":"JD.com Makes History with Record-Breaking Singles' Day Performance, Securing Industry Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1143508794","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143508794?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:21","pubTimestamp":1763036470,"startTime":"0","endTime":"0","summary":"Liu Qiangdong, the driving force behind JD.com, has always emphasized that striving to be the best is the core spirit of the company and the value that propels its continuous leadership in the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1502","BK4551","BK1591","LU0140636845.USD","LU1044876610.USD","LU0259732245.USD","LU0588545904.SGD","LU1366334651.USD","SG9999002828.SGD","LU0431992006.USD","SGXZ86797644.SGD","LU1282649067.USD","HK0000320223.HKD","LU1719994722.HKD","LU0499858602.USD","BK4531","LU0588545490.SGD","LU1770036033.HKD","BK1588","LU0320764755.SGD","LU0370786039.SGD","LU0871576103.HKD","LU0307460666.USD","LU1282651048.USD","LU0791590937.USD","LU0315178854.USD","LU1770034418.SGD","LU0672654166.SGD","IE00B3M56506.USD","LU0488056044.USD","LU0164880469.USD","06618","LU0543330483.HKD","LU0828237510.HKD","LU0463099449.HKD","HK0000320264.USD","LU0865486749.SGD","LU1044875133.USD","BK4588","BK4504","BK1610","BK4509","LU0051755006.USD","LU0228659784.USD","89618","LU1251922891.USD","LU0052750758.USD","IE00B29SXG58.USD","LU0791591158.USD","LU1044874839.SGD","BK1619","LU0588545730.USD","LU0594300419.USD","LU0106959298.USD","LU1808992512.USD","LU0048580855.USD","BK4505","SG9999001226.SGD","LU0029875118.USD","LU0228367735.SGD","BK1249","BK1247","BK4220","LU1023057109.AUD","HK0000306701.USD","LU0164865239.USD","BK4614","BK4503","BK4579","LU0244354667.USD","LU1720050803.USD","09618","BK1575","LU2257852520.SGD","LU0359201885.HKD","LU1224444064.USD","LU0149721374.USD","BK1515","SG9999002562.SGD","LU0128522157.USD","LU0456846285.SGD","LU1366334578.USD","LU0348805143.USD","LU0384037296.USD","LU2242644610.SGD","IE0008368742.USD","BK1583","LU0326950275.SGD","LU0650527681.SGD","LU0359202008.SGD","BK1142","IE00BGV7N243.SGD","LU2039709279.SGD","SG9999002463.SGD","LU1642822792.SGD","BK1571","LU0315179316.USD","LU0039217434.USD","IE0032431581.USD","LU0211977185.USD","BK4524","LU0293314216.USD","LU1813983027.USD","LU1328277881.USD","LU0708995583.HKD","LU0456827905.SGD","BK1589","LU0469268626.HKD","LU0868486357.SGD","BK4122","LU0359201612.USD","BK4558","LU0314109678.HKD","LU0588546209.SGD","LU1188198961.HKD","LU1794554557.SGD","LU0348825331.USD","LU0348735423.USD","SGXZ62798434.SGD","BK4526","LU0320764599.SGD","LU1481107354.HKD","LU0327786744.USD","LU0499858438.USD","LU1880383366.USD","LU0572944931.SGD","LU0163747925.USD","LU0456842615.SGD","LU0345775950.USD","86618","BK1615","LU0231483743.USD","LU0345776255.USD","LU0084288322.USD","JD","LU0417516902.SGD","BK4585","LU1282651121.HKD","HK0000306685.HKD","LU0417516738.SGD","LU1688375341.USD","LU1282649810.SGD","LU1303224171.USD","LU0531971595.HKD"],"gpt_icon":1},{"id":"1106791120","title":"Daxing Airport Economic Zone Global Investment Partner Conference Unveils Major Collaboration Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1106791120","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106791120?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:01","pubTimestamp":1763035268,"startTime":"0","endTime":"0","summary":"Gathering momentum at the new national gateway, leading the way to a new future. On November 12, the 2025 Fifth Daxing Airport Economic Zone Global Investment Partner Conference, themed \"Gathering...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2583756199","title":"CanSino Biologics Begins Phase 1 Trial of Tuberculosis Booster Vaccine in Indonesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2583756199","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583756199?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:35","pubTimestamp":1763033737,"startTime":"0","endTime":"0","summary":"CanSino Biologics  initiated the phase 1 clinical trial of its inhaled tuberculosis vaccine in Indonesia recently and the first patient has been enrolled, a Thursday Hong Kong bourse filing said.The phase Ia and Ib trials for the vaccine were completed in Canada, with data demonstrating its safety and its effectiveness as a Bacillus Calmette-Guerin booster vaccine.Bacillus Calmette-Guerin is reportedly the only available tuberculosis vaccine in the world currently.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06185","BK1574","BK1515","BK1191"],"gpt_icon":0},{"id":"2583565967","title":"JD Health International's Profit Balloons 97% in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2583565967","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583565967?lang=en_us&edition=fundamental","pubTime":"2025-11-13 18:24","pubTimestamp":1763029491,"startTime":"0","endTime":"0","summary":"JD Health International  recorded a 97% rise in profit in the third quarter to 1.84 billion yuan from 932.2 million yuan a year prior, a Thursday Hong Kong bourse filing said.The online healthcare platform operator's revenue rose 29% in the quarter to 17.1 billion yuan from 13.3 billion yuan in the year-ago period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1188198961.HKD","SGXZ62798434.SGD","06618","BK4551","LU0326950275.SGD","BK4220","BK4558","HK0000320223.HKD","LU0588546209.SGD","BK1515","LU1880383366.USD","BK1589","BK1142","IE00BGV7N243.SGD","BK1571","LU0456827905.SGD","BK1591","BK4509","SGXZ86797644.SGD","86618","LU0051755006.USD","SG9999002463.SGD","LU0463099449.HKD","BK4614","BK1615","IE0008368742.USD","BK1247","BK4122","LU1688375341.USD","BK4503","LU0106959298.USD","HK0000306685.HKD","BK4526","HK0000320264.USD","BK1583","BK4505","BK4531","HK0000306701.USD","LU0307460666.USD","BK4504","LU0244354667.USD","BK4588","BK4524","BK4579","BK4585"],"gpt_icon":0},{"id":"2583955720","title":"JD Health International Inc. Announces Date for Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2583955720","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583955720?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:07","pubTimestamp":1763024841,"startTime":"0","endTime":"0","summary":"JD Health International Inc. has announced that it will hold an Extraordinary General Meeting on December 8, 2025, at Building C, Campus 2, No. 20 Kechuang 11 Street, BDA, Beijing, China. Shareholders will have the opportunity to vote on various ordinary resolutions as set out in the notice of the Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL8XFqT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["89618","LU1282649067.USD","BK1575","LU0588545904.SGD","LU1719994722.HKD","LU0315179316.USD","IE00B3M56506.USD","LU0140636845.USD","LU1770034418.SGD","LU1366334578.USD","LU0163747925.USD","BK1515","BK1615","LU0499858438.USD","LU1720050803.USD","LU0307460666.USD","LU1366334651.USD","LU0314109678.HKD","LU0499858602.USD","LU0320764599.SGD","86618","IE00BGV7N243.SGD","BK1589","LU0543330483.HKD","LU1813983027.USD","SGXZ62798434.SGD","LU0164865239.USD","LU1044875133.USD","LU1251922891.USD","SGXZ86797644.SGD","LU0327786744.USD","LU1282651048.USD","BK1142","LU0708995583.HKD","BK1247","IE00B29SXG58.USD","LU0348735423.USD","LU2039709279.SGD","SG9999001226.SGD","LU0048580855.USD","LU0231483743.USD","BK1591","SG9999002562.SGD","LU0791591158.USD","LU0588546209.SGD","LU0128522157.USD","06618","LU2242644610.SGD"],"gpt_icon":1},{"id":"1193091303","title":"JD HEALTH (06618) Reports Q3 Earnings with Operating Profit of RMB1.243 Billion, Up 125.3% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1193091303","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193091303?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:52","pubTimestamp":1763023951,"startTime":"0","endTime":"0","summary":"JD HEALTH (06618) announced its financial results for the third quarter of 2025, achieving revenue of RMB17.12 billion, a year-on-year increase of 28.7%. Operating profit surged to RMB1.243 billion,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","LU0051755006.USD","SGXZ86797644.SGD","BK1142","BK1515","BK1615","LU0456827905.SGD","BK1589","86618","06618","BK1247","BK1583","BK1571","BK1591"],"gpt_icon":0},{"id":"2583557831","title":"JD Health International Inc. Shareholders to Vote on Proxy Proposal for Renewal of Continuing Connected Transactions at Upcoming EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2583557831","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583557831?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:51","pubTimestamp":1763023872,"startTime":"0","endTime":"0","summary":"JD Health International Inc. Shareholders to Vote on Proxy Proposal for Renewal of Continuing Connected Transactions at Upcoming EGM. JD Health International Inc. has announced that shareholders will vote on the renewal of existing continuing connected transactions at an Extraordinary General Meeting scheduled for December 8, 2025. The Board's Independent Committee has recommended that shareholders vote in favour of the proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL1jzfGs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU0140636845.USD","LU2039709279.SGD","LU0128522157.USD","LU0320764599.SGD","SG9999002562.SGD","SGXZ62798434.SGD","LU1282651048.USD","SG9999001226.SGD","LU0588546209.SGD","06618","IE00B29SXG58.USD","LU0163747925.USD","LU0048580855.USD","LU1366334578.USD","IE00BGV7N243.SGD","86618","LU0164865239.USD","LU1719994722.HKD","BK1589","LU1366334651.USD","BK1615","LU0315179316.USD","LU1720050803.USD","LU0791591158.USD","BK1591","LU1044875133.USD","SGXZ86797644.SGD","LU1813983027.USD","LU0499858438.USD","LU0708995583.HKD","BK1515","BK1575","LU0231483743.USD","LU0314109678.HKD","LU0327786744.USD","LU0588545904.SGD","LU0348735423.USD","LU0543330483.HKD","IE00B3M56506.USD","LU1251922891.USD","BK1142","LU2242644610.SGD","89618","LU0499858602.USD","BK1247","LU1770034418.SGD","LU1282649067.USD"],"gpt_icon":1},{"id":"2583552110","title":"BRIEF-JD Health International Posts Qtrly Non-IFRS Profit RMB1.90 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2583552110","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583552110?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:40","pubTimestamp":1763023253,"startTime":"0","endTime":"0","summary":"BRIEF-JD Health International Posts Qtrly Non-IFRS Profit RMB1.90 BillionNov 13 (Reuters) - JD Health International Inc 6618.HK:QTRLY NON-IFRS PROFIT RMB1.90 BILLIONQTRLY REVENUE RMB17.12 BILLIONFurther company coverage: 6618.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL8N3WP0I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1589","BK1615","BK1247","BK1142","SGXZ62798434.SGD","06618","BK1571","LU0051755006.USD","LU0456827905.SGD","BK1591","SGXZ86797644.SGD","86618","BK1515"],"gpt_icon":0},{"id":"2583552349","title":"JD Health International Reports Strategic Partnerships and New Drug Launches in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583552349","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583552349?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:39","pubTimestamp":1763023191,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL99GGF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014914.USD","LU0502904849.HKD","LU1868837136.USD","LU1868836914.USD","89618","LU1044875133.USD","LU1868836757.USD","IE00BK4W5L77.USD","LU0029875118.USD","LU1023057109.AUD","SG9999013999.USD","LU2488822045.USD","BK1142","01801","06618","LU0543330483.HKD","LU0417517546.SGD","LU2746668461.USD","LU1044876610.USD","LU0314109678.HKD","BK1515","IE0002141913.USD","LU1868836591.USD","LU0471298777.SGD","LU2746668974.SGD","SG9999015952.SGD","LU1551013425.SGD","LU0672654166.SGD","LU2264538146.SGD","SGXZ62798434.SGD","BK1588","LU0871576103.HKD","86618","BK1589","LU1291159041.SGD","LU2257852520.SGD","LU0320764599.SGD","LU1035775433.USD","LU1548497426.USD","LU1328277881.USD","SG9999014906.USD","SGXZ86797644.SGD","LU0259732245.USD","IE0009355771.USD","LU1642822792.SGD","LU0672654240.SGD","SG9999017495.SGD"],"gpt_icon":1},{"id":"2583823552","title":"JD Health International - Qtrly Revenue RMB17.12 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2583823552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583823552?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:37","pubTimestamp":1763023021,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGXZ62798434.SGD","BK1615","BK1583","SGXZ86797644.SGD","BK1591","BK1247","BK1515","86618","BK1589","LU0051755006.USD","BK1142","BK1571","LU0456827905.SGD","06618"],"gpt_icon":0},{"id":"2583555474","title":"CSPC Pharmaceutical Group Stock Rallies 3.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2583555474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583555474?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:31","pubTimestamp":1763022660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 3.8% to 7.95 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 27073.03.This was the stock's second consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 32% below its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 6.5%, SSY Group Ltd. remained unchanged, and United Laboratories International Holdings Ltd. rose 1.8%.Trading volume totaled 156.7 million shares, compared to the 50-day average of 149.8 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YS42.EUR","LU1807302812.USD","LU1226288170.HKD","01093","LU1008478684.HKD","LU0072913022.USD","SG9999004220.SGD","LU1993786604.SGD","LU0326950275.SGD","IE00B543WZ88.USD","IE00BZ08YT58.USD","BK1521","LU1226288253.USD","LU0067412154.USD","LU1152091168.USD","LU2039709279.SGD","HK0000165453.HKD","IE0008368742.USD","LU1226287875.USD","LU1960683339.HKD","LU1328277881.USD","LU0140636845.USD","IE0008369823.USD","LU0501845795.SGD","LU1226287529.USD","LU1813983027.USD","IE00B031HY20.USD","LU0314109678.HKD","LU0880133367.SGD","BK1191","LU0315179316.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1226287792.SGD"],"gpt_icon":0},{"id":"1173746546","title":"IPO Preview: Can Haina Pharma's \"CXO + Proprietary Pipeline\" Model Shine in Hong Kong?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173746546","media":"Stock News","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173746546?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022626,"startTime":"0","endTime":"0","summary":"Nanjing Haina Pharmaceutical Technology Co., Ltd. (Haina Pharma) has submitted its IPO application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as its sole...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","BK1161","CXO","159938","BK1574"],"gpt_icon":0},{"id":"1195028229","title":"AH Premium Rate and Deviation Rankings as of November 13","url":"https://stock-news.laohu8.com/highlight/detail?id=1195028229","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195028229?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:19","pubTimestamp":1763021946,"startTime":"0","endTime":"0","summary":"As of the market close on November 13, NE ELECTRIC (00042), SINOPEC SSC (01033), and HOLLY FUTURES (03678) ranked as the top three stocks with the highest AH premium rates, at 847.37%, 268.24%, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","BK1535","IE00B543WZ88.USD","LU1008478684.HKD","LU1366334651.USD","LU0868486357.SGD","IE00BMCWC346.EUR","LU1880383440.USD","LU0791590937.USD","IE0034224299.USD","LU0348735423.USD","LU0345780281.USD","LU0181495838.USD","LU0516423174.USD","IE0031814852.USD","LU0348827113.USD","LU0918141887.USD","LU1105468828.SGD","LU0229945570.USD","BK1610","LU0269904917.USD","LU1655091616.SGD","BK1505","LU0456827905.SGD","LU1769817096.USD","02465","LU1224709979.USD","SG9999002463.SGD","LU0117841782.USD","BK1105","00042","LU2097828805.USD","LU0561508036.HKD","LU0096374516.USD","BK1140","LU0862451753.SGD","LU0634319403.HKD","LU1807302812.USD","LU0871576103.HKD","IE00B3M56506.USD","LU2097828631.EUR","IE00BGHQDM52.EUR","BK1148","159982","LU0359201885.HKD","BK1537","LU0501845795.SGD","LU1242518931.SGD","01812","LU0469268626.HKD","LU0972618739.USD","LU0456846285.SGD","SG9999004220.SGD","LU0797268264.HKD","LU0509642566.USD","LU1504937902.USD","SG9999006597.SGD","LU0314109678.HKD","BK1183","IE00BZ08YR35.GBP","LU0979878070.USD","LU0588546209.SGD","SG9999012728.SGD","LU0163747925.USD","LU1880383366.USD","LU0327786744.USD","LU1211504680.USD","BK1124","00187","BK1564","LU0516422366.SGD","LU0593848301.USD","LU0828238088.HKD","LU0164865239.USD","SG9999012744.USD","LU1481107354.HKD","HK0000320223.HKD","LU0039217434.USD","LU0348805143.USD","LU2242644610.SGD","00670","LU0106959298.USD","BK1123","LU1188198961.HKD","IE00B031J352.USD","LU0540923850.HKD","02068","LU0516423091.SGD","LU0737861699.HKD","LU0890818403.SGD","LU1251922891.USD","LU0828237510.HKD","LU2097828714.EUR","BK1523","IE00B0169L03.USD","LU0315179316.USD","02218","BK1191","BK1552","LU1242518857.USD","LU1785774172.SGD","LU2476274720.SGD","BK1223","LU2476274308.USD","LU0502904849.HKD","LU1960683339.HKD","BK1509","BK1110","LU0488056044.USD","SG9999002828.SGD","BK1550","LU0326950275.SGD","LU1770034418.SGD","BK1237","LU0348814723.USD","LU0431992006.USD","LU2226246903.HKD","LU1688375341.USD","00874","LU1366334578.USD","BK1554","LU0886674414.USD","LU0648948544.HKD","LU0052750758.USD","SG9999012710.SGD","IE00BYV24P56.USD","01138","LU2125910500.SGD","02338","LU2399975544.HKD","BK1562","IE00B5MMRT66.SGD","01772","LU0051755006.USD","BK1515","LU0231483743.USD","LU0823426308.USD","LU0455707207.USD","LU0228659784.USD","LU0359201612.USD","LU0640798160.USD","01057","BK1514","BK1184","IE0032431581.USD","LU0320764599.SGD","LU1794554557.SGD","LU2045819591.USD","IE00B031HY20.USD","LU0531971595.HKD","BK1141","00568","03606","BK1583","LU1115378108.SGD","LU0516422952.EUR","LU0140636845.USD","LU1282649141.HKD","01108","01055","02628","LU1813983027.USD","LU0061477393.USD","LU1282649810.SGD","LU1152091754.HKD","BK1166","IE00BF5LJ272.USD","LU0106252389.USD","LU0708995583.HKD","LU1719994722.HKD","01033","BK1147","BK1584","LU0266512473.USD","BK1551","03993","LU1720050803.USD","03678","SG9999012736.USD","LU0164880469.USD","IE0008369823.USD","BK1190","BK1197","LU0287142896.SGD","BK1546","LU0348788117.USD","LU0384037296.USD","LU0823426480.USD","LU0828237940.HKD","BK1202","01349","LU1023057109.AUD","LU2097828474.EUR","LU0821914370.USD","LU0516422440.USD","LU1328277881.USD","03143","LU0072913022.USD","LU0456854461.SGD","LU1152091168.USD","LU1282649067.USD","SG9999003461.SGD","BK1144","LU0228367735.SGD","01276","SG9999014674.SGD","LU0543330566.HKD","02899","BK1198","BK1544","LU1808992512.USD","LU2039709279.SGD","LU0173614495.USD","BK1592","LU0266512127.USD","00300","BK1507","BK1171","BK1576","LU0211977185.USD","IE0008368742.USD","06869","IE00B29SXG58.USD","LU1769817179.HKD","LU0359202008.SGD","LU0463099449.HKD","BK1506","LU2097828557.USD","LU1046422090.SGD","HK0000306701.USD","LU0348816934.USD","IE00BVYPNP33.GBP","LU0348825331.USD","03968","LU1048596156.SGD","LU0345780521.USD","02866","LU0370786039.SGD","02359","LU0918141705.HKD","399300","BK1116","LU2543165471.USD","HK0000306685.HKD","03750","LU0791591158.USD","LU0417516902.SGD","LU1226287529.USD","BK1606","LU0307460666.USD","LU1675838814.USD","BK1149","LU0244354667.USD","LU0417516738.SGD","LU0067412154.USD","LU2778985437.USD","LU0328353924.USD","LU0149721374.USD","IE00BZ08YS42.EUR","LU1831875114.USD","BK1594","BK1521","LU0880133367.SGD","HK0000320264.USD","LU0048580855.USD","BK1129","BK1561","LU1303224171.USD","00895","06031","BK1214","HK0000165453.HKD","00638","BK1231","LU0049853897.USD","LU1961090484.USD","IE00BVYPNQ40.USD","LU1993786604.SGD","BK1560","LU0589944569.HKD","BK1522","01375","IE00BZ08YT58.USD","LU1282648689.USD"],"gpt_icon":1},{"id":"1192830237","title":"HK Stock Movement | GENFLEET-B (02595) Surges Over 8% in Late Trading as GFH375 Tablets Enter Phase III Clinical Trial for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1192830237","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192830237?lang=en_us&edition=fundamental","pubTime":"2025-11-13 15:58","pubTimestamp":1763020694,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) rose more than 8% in late trading, closing up 7.46% at HK$31.1 with a turnover of HK$28.08 million. On November 11, the drug clinical trial registration platform revealed that...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","09939","02595","BK1161","BK4134","159938","III","BK1574"],"gpt_icon":0},{"id":"1126925116","title":"IPO Preview | Weijian Pharma: Doubling H1 2025 Revenue Ahead of Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1126925116","media":"Stock News","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126925116?lang=en_us&edition=fundamental","pubTime":"2025-11-13 14:46","pubTimestamp":1763016389,"startTime":"0","endTime":"0","summary":"Weijian Pharma, China's leading pharmaceutical company with the largest portfolio of commercialized innovative drugs for kidney diseases, has filed for its Hong Kong IPO. On November 7, the company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","159938","BK1515","BK1161"],"gpt_icon":0},{"id":"1177484884","title":"CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1177484884","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177484884?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:18","pubTimestamp":1763007490,"startTime":"0","endTime":"0","summary":"CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06618","BK1617","BK1583","BK1197","BK1247","BK1571","BK1589","LU0051755006.USD","BK1591","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1615","09955","LU0456827905.SGD","86618","BK1515","BK1142"],"gpt_icon":0},{"id":"2583531432","title":"ClouDr Group - Agreement to Expand Online Sales for Remifemin, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2583531432","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583531432?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:02","pubTimestamp":1763006530,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WO1MS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1197","BK1615","06618","86618","09955","BK1589","SGXZ62798434.SGD","LU0051755006.USD","BK1617","BK1247","BK1583","SGXZ86797644.SGD","BK1591","LU0456827905.SGD","BK1142","BK1571"],"gpt_icon":0},{"id":"2583314375","title":"ClouDr Group Ltd - Enters Service Cooperation Agreement With JD Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2583314375","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583314375?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:02","pubTimestamp":1763006530,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WO1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","09955","BK1247","LU0456827905.SGD","BK1197","06618","BK1615","BK1515","LU0051755006.USD","SGXZ86797644.SGD","BK1617","BK1589","BK1571","BK1142","SGXZ62798434.SGD","BK1591","86618"],"gpt_icon":0},{"id":"1190620025","title":"ASCLETIS-B (01672) Rises Over 4% Again as ASC36 and ASC35 Combo Advances to Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1190620025","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190620025?lang=en_us&edition=fundamental","pubTime":"2025-11-13 10:30","pubTimestamp":1763001025,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) surged over 4% again, trading at HK$11.68 by the latest update, up 3.55%, with a turnover of HK$8.54 million. The company announced that its monthly next-generation amylin receptor...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01477","BK1161","BK1574","BK1191","01672"],"gpt_icon":0},{"id":"1185751714","title":"Pharmaceutical Sector Boosted as FDA Leadership Change Restores Market Confidence, Drug Stocks Hit Record Highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1185751714","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185751714?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:20","pubTimestamp":1762996824,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) announced the appointment of Richard Pazdur, its top cancer drug reviewer, as Director of the Center for Drug Evaluation and Research, driving global...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","09939","01477","159938","BK1574","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":189,"code":"91000000","status":"200"}]}}